Literature DB >> 26269171

Viral Source-Independent High Susceptibility of Dendritic Cells to Human T-Cell Leukemia Virus Type 1 Infection Compared to That of T Lymphocytes.

Sandrine Alais1, Renaud Mahieux1, Hélène Dutartre2.   

Abstract

UNLABELLED: Human T-cell leukemia virus type 1 (HTLV-1)-infected CD4(+) T cells and dendritic cells (DCs) are present in peripheral blood from HTLV-1 carriers. While T-cell infection requires cell-cell contact, DCs might be infected with cell-free virus, at least in vitro. However, a thorough comparison of the susceptibilities of the two cell types to HTLV-1 infection using cell-associated and cell-free viral sources has not been performed. We first determined that human primary monocyte-derived dendritic cells (MDDCs) were more susceptible to HTLV-1 infection than their autologous lymphocyte counterparts after contact with chronically infected cells. Next, a comparison of infection efficiency using nonconcentrated or concentrated supernatants from infected cells as well as purified viral biofilm was performed. Integrated provirus was found after exposure of MDDCs or primary lymphocytes to viral biofilm but not to a viral supernatant. Using a large series of primary cell samples (n = 21), we demonstrated a higher proviral load in MDDCs exposed to viral biofilm than in lymphocytes. This higher susceptibility is correlated to a higher expression of neuropilin-1 on MDDCs than on autologous activated T lymphocytes. Moreover, we show that MDDCs infected with viral biofilm can transmit the virus to lymphocytes. In conclusion, MDDCs are more susceptible to HTLV-1 infection than autologous lymphocytes in vitro, supporting a model in which DC infection might represent an important step during primo-infection in vivo. IMPORTANCE: HTLV-1 is able to infect several cell types, but viral DNA is mainly found in T lymphocytes in vivo. This supports a model in which T lymphocytes are the main target of infection. However, during the primo-infection of new individuals, incoming viruses might first encounter dendritic cells (DCs), the specialized immune cells responsible for the antiviral response of the host. HTLV-1 cell-free purified viruses can infect dendritic cells in vitro, while T-cell infection is restricted to cell-to-cell transmission. In order to understand the sequence of HTLV-1 dissemination, we undertook a direct comparison of the susceptibilities of the two cell types using cell-associated and cell-free viral sources. We report here that MDDCs are more susceptible to HTLV-1 infection than autologous lymphocytes in vitro and are able to efficiently transmit the virus to lymphocytes. Our results suggest that DCs may represent a true viral reservoir, as the first cell type to be infected in vivo.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26269171      PMCID: PMC4580172          DOI: 10.1128/JVI.01799-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia.

Authors:  M Makino; S Wakamatsu; S Shimokubo; N Arima; M Baba
Journal:  Virology       Date:  2000-08-15       Impact factor: 3.616

Review 2.  Discovery of ATL: an odyssey in restrospect.

Authors:  Junji Yodoi; Michiyuki Maeda
Journal:  Int J Hematol       Date:  2011-11-09       Impact factor: 2.490

Review 3.  HTLV-1 tropism and envelope receptor.

Authors:  Nicolas Manel; Jean-Luc Battini; Naomi Taylor; Marc Sitbon
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

4.  HTLV-1 associated myelopathy (HAM).

Authors:  M Osame; A Igata; M Matsumoto; S Izumo; K Usuku; R L Rosales; M Tara
Journal:  Kansenshogaku Zasshi       Date:  1988-03

5.  Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton.

Authors:  Tadahiko Igakura; Jane C Stinchcombe; Peter K C Goon; Graham P Taylor; Jonathan N Weber; Gillian M Griffiths; Yuetsu Tanaka; Mitsuhiro Osame; Charles R M Bangham
Journal:  Science       Date:  2003-02-13       Impact factor: 47.728

6.  Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals.

Authors:  Masakatsu Hishizawa; Kazunori Imada; Toshio Kitawaki; Maki Ueda; Norimitsu Kadowaki; Takashi Uchiyama
Journal:  Br J Haematol       Date:  2004-06       Impact factor: 6.998

7.  Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.

Authors:  Kathryn S Jones; Cari Petrow-Sadowski; Ying K Huang; Daniel C Bertolette; Francis W Ruscetti
Journal:  Nat Med       Date:  2008-03-23       Impact factor: 53.440

8.  The cellular autophagy pathway modulates human T-cell leukemia virus type 1 replication.

Authors:  Sai-Wen Tang; Chia-Yen Chen; Zachary Klase; Linda Zane; Kuan-Teh Jeang
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

Review 9.  Current concepts regarding the HTLV-1 receptor complex.

Authors:  David Ghez; Yves Lepelletier; Kathryn S Jones; Claudine Pique; Olivier Hermine
Journal:  Retrovirology       Date:  2010-11-29       Impact factor: 4.602

10.  HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice.

Authors:  Julien Villaudy; Mélanie Wencker; Nicolas Gadot; Nicolas A Gillet; Jean-Yves Scoazec; Louis Gazzolo; Markus G Manz; Charles R M Bangham; Madeleine Duc Dodon
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more
  36 in total

1.  Essential Role of Human T Cell Leukemia Virus Type 1 orf-I in Lethal Proliferation of CD4+ Cells in Humanized Mice.

Authors:  Veronica Galli; Christopher C Nixon; Natasa Strbo; Maria Artesi; Maria F de Castro-Amarante; Katherine McKinnon; Dai Fujikawa; Maria Omsland; Robyn Washington-Parks; Laura Romero; Breanna Caruso; Keith Durkin; Sophia Brown; Baktiar Karim; Monica Vaccari; Steve Jacobson; Jerome A Zack; Anne Van den Broeke; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Factor Upregulates the Expression of ICAM-1 To Facilitate HTLV-1 Infection.

Authors:  Ana Laura Fazio; Wesley Kendle; Kimson Hoang; Erica Korleski; Isabelle Lemasson; Nicholas Polakowski
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

Review 3.  Cell-Free versus Cell-to-Cell Infection by Human Immunodeficiency Virus Type 1 and Human T-Lymphotropic Virus Type 1: Exploring the Link among Viral Source, Viral Trafficking, and Viral Replication.

Authors:  Hélène Dutartre; Mathieu Clavière; Chloé Journo; Renaud Mahieux
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

4.  Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.

Authors:  Céline Curis; Florent Percher; Patricia Jeannin; Thomas Montange; Sébastien A Chevalier; Danielle Seilhean; Luis Cartier; Pierre-Olivier Couraud; Olivier Gout; Antoine Gessain; Pierre-Emmanuel Ceccaldi; Philippe V Afonso
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

5.  Human T Cell Leukemia Virus Type 1 Infection of the Three Monocyte Subsets Contributes to Viral Burden in Humans.

Authors:  Maria Fernanda de Castro-Amarante; Cynthia A Pise-Masison; Katherine McKinnon; Robyn Washington Parks; Veronica Galli; Maria Omsland; Vibeke Andresen; Raya Massoud; Giovanna Brunetto; Breanna Caruso; David Venzon; Steven Jacobson; Genoveffa Franchini
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

6.  Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.

Authors:  Manraj Singh Narulla; Ahlam Alsairi; Lucie Charmier; Stephen Noonan; David Conroy; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

Review 7.  Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission.

Authors:  Christine Gross; Andrea K Thoma-Kress
Journal:  Viruses       Date:  2016-03-09       Impact factor: 5.048

8.  Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo.

Authors:  James M Fox; Silva Hilburn; Maria-Antonietta Demontis; David W Brighty; Maria Fernanda Rios Grassi; Bernardo Galvão-Castro; Graham P Taylor; Fabiola Martin
Journal:  Viruses       Date:  2016-03-14       Impact factor: 5.048

Review 9.  HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.

Authors:  Nicolas Futsch; Renaud Mahieux; Hélène Dutartre
Journal:  Viruses       Date:  2017-12-21       Impact factor: 5.048

Review 10.  Molecular Studies of HTLV-1 Replication: An Update.

Authors:  Jessica L Martin; José O Maldonado; Joachim D Mueller; Wei Zhang; Louis M Mansky
Journal:  Viruses       Date:  2016-01-27       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.